Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Diet Therapy × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 13 Genitourinary 11 Gastrointestinal 11 Gynecologic 8 Other 7 Lymphoid 3 CNS 3 Sarcoma 2 Other solid neoplasm 2 Other hematologic neoplasm 2 Dermatologic 2 Thoracic 1 Plasma cell 1 NET 1 Myeloid 1 Head & Neck 1 Endocrine 1

Conditions

Neuroendocrine Tumors 1

Interventions

lutetium Lu 177 dotatate 2 Lutetium-177 2 Liquid Biopsy 2 Endoscopic Mucosal Resection 2 Data Collection 2 pentetreotide 1 fluorodopa F 18 1 copper dotatate CU-64 1 Yttrium-90 1 Surveys and Questionnaires 1 Standard of Care 1 Specimen Handling 1 Single Photon Emission Computed Tomography Computed Tomography 1 Serum Albumin 1 Resveratrol 1 Respiratory Therapy 1 Referral and Consultation 1 Radiofrequency Ablation 1 Quality of Life 1 Poly(ADP-ribose) Polymerase Inhibitors 1 Octreotide 1 Nutrition Assessment 1 Needles 1 Magnetic Resonance Spectroscopy 1 Drug Therapy 1 Diet Therapy 1 Cryosurgery 1 Control Groups 1 Betaine 1 90Y-octreotide, DOTA-Tyr(3)- 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02481804 2024-05-06

DIVIT-pilot

University Medical Center Groningen

Phase NA Completed

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡